HK Stock MarketDetailed Quotes

02291 SCIENTECH

Watchlist
  • 17.780
  • -0.860-4.61%
Noon Break Nov 27 11:39 CST
6.17BMarket Cap26.03P/E (TTM)

About SCIENTECH Company

Lepuxintai Medical Technology (Shanghai) Co., Ltd. is committed to providing safe, effective and innovative medical solutions. It is a pioneer in the structural heart disease interventional medical device industry in China and a large-scale domestic supplier of congenital heart disease blocking devices. Focus on R&D, production and marketing of medical interventional devices for structural heart disease. Currently, there are 50 products on the market and under development. The product line covers the congenital blocker series for interventional treatment of congenital heart disease, the left ventricular occlusion series for the prevention of cardiogenic stroke and the unclosed occlusion of the ovary, etc., and the biological interventional valve series for treatment of valve stenosis and incomplete closure, which can provide a comprehensive solution for structural heart disease interventional treatment. Our products have been sold overseas to 44 countries and regions in Asia, Europe, America and Africa. The company has strong R&D capabilities, has many innovative products with independent intellectual property rights, and is first involved in the research and development of biodegradable technology. In 2009, the “Development and Clinical Application of Interventional Treatment Series Blockers and Related Devices for Interventional Treatment of Defective Congenital Heart Disease” project won the second prize of the National Science and Technology Progress Award. As of October 18, 2022, the company has 232 registered intellectual property rights. In the future, the company will continue to invest in research and development, continuously develop new products and technologies to benefit more patients with structural heart disease and contribute to the cause of human health.

Company Profile

Symbol02291
Company NameSCIENTECH
ISINCNE1000057M5
Listing DateNov 8, 2022
Issue Price29.15
Shares Offered22.46M share(s)
FoundedJan 29, 2021
Registered AddressChina
Chairmanjuan chen
Secretaryxuelijianwei qin
Audit InstitutionLixin Certified Public Accountants (Special General Partnership)
Company CategoryMainland registration of Mainland Individuals control
Registered OfficeRoom 201, Building 41, No. 258, Xinzhuan Road, Songjiang District, Shanghai, China
Head Office and Principal Place of Business5th Floor, Manulife Plaza, 348 Kwun Tong Road, Kowloon, Hong Kong
Fiscal Year Ends12-31
Employees239
MarketHong Kong motherboard
Phone(021)37015600;(86)(21)37015633
EmailIR@scientechmed.com
Business Lepuxintai Medical Technology (Shanghai) Co., Ltd. is a Chinese investment holding company mainly engaged in R&D, manufacturing and commercialization of interventional medical devices for structural heart diseases. The company mainly operates through two divisions. The blocker business division is mainly engaged in the development and sale of a series of blockers for interventional treatment of defective congenital heart disease. The Heart Valve Business Division is mainly engaged in the research and development of heart valve medical devices. The company mainly operates in the domestic market of China.

Company Executives

  • Name
  • Position
  • Salary
  • juan chen
  • Chairman, Executive Director, General Manager, Chairman of the Nomination Committee, Remuneration Committee Members, Authorized Representative
  • --
  • yuxin zhang
  • Non-executive Directors
  • --
  • shan fu
  • Non-executive Directors, Remuneration Committee Members
  • --
  • guorui zheng
  • Non-executive Directors, Audit Committee Members, Nomination Committee Members
  • --
  • jiali chen
  • Independent Non-Executive Director, Chairman of the Audit Committee, Remuneration Committee Member, Nomination Committee Members
  • --
  • junwei zheng
  • Independent Non-Executive Director, Nomination Committee Members, Remuneration Committee Members
  • --
  • yufeng zheng
  • Independent Non-Executive Director, Remuneration Committee Chairman, Audit Committee Members, Nomination Committee Members
  • --
  • xinglin wang
  • Auditors
  • --
  • xiaoyong wang
  • Auditors
  • --
  • weidong qian
  • Employees Representing Supervisors
  • --
  • xue qin
  • Deputy General Manager, Chief Financial Officer, Joint Company Secretary
  • --
  • yufeng he
  • Deputy General Manager, Chief Operating Officer
  • --
  • xiani zhang
  • Deputy General Manager
  • --
  • zhangya liao
  • Group Deputy General Manager
  • --
  • jiadan luo
  • Group Deputy General Manager
  • --
  • kejin qiu
  • R&D Director of Valve Division
  • --
  • jinpeng hu
  • R&D Director of Blockers Division
  • --
  • jianwei li
  • Joint Company Secretary, Authorized Representative
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data